Serum JKAP as a potential prognostic biomarker in acute coronary syndrome patients undergoing percutaneous coronary intervention

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2025-12-12
DOI
https://doi.org/10.3389/fcvm.2025.1631896
Primary Topic
Cardiac Fibrosis and Remodeling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum JKAP as a potential prognostic biomarker in acute coronary syndrome patients undergoing percutaneous coronary intervention

Frontiers in Cardiovascular Medicine
Cardiac Fibrosis and Remodeling
article

Serum JKAP as a potential prognostic biomarker in acute coronary syndrome patients undergoing percutaneous coronary intervention

article en

Abstract

No abstract available for this paper.
Frontiers in Cardiovascular MedicineVol. 12
Fujian Medical University (CN), Fujian Provincial Hospital (CN)
Good health and well-being
Openalex Percentile: Top 32%
Cardiac Fibrosis and Remodeling
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Serum JKAP as a potential prognostic biomarker in acute coronary syndrome patients undergoing percutaneous coronary intervention · Frontiers in Cardiovascular Medicine (2025) | TGRS Research Map | TGRS